The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Oncoprotein Bmi-1 Renders Apoptotic Resistance to Glioma Cells through Activation of the IKK-Nuclear Factor-κB Pathway
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, the activation of PRCs, evident from increased expression of BMI1 and SUZ12,77 contributed to the radio-resistance of tumor cells,137,138 including glioblastoma.139,140”
From MiR-128-3p – a gray eminence of the human central nervous system (2024) · cites this paper as [140]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glinsky, G. V., Berezovska, O., & Glinskii, A. B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23412 · Cited by 916
Ishii, N., Maier, D., Merlo, A., Tada, M., Sawamura, Y., Diserens, A., & Van Meir, E. G. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00536.x · Cited by 569
Shin, H.-M., Kim, M.-H., Kim, B. H., Jung, S.-H., Kim, Y. S., Park, H. J., Hong, J. T., Min, K. R., & Kim, Y. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.056 · Cited by 269
Research works printed but not linked: 30
- Wen, 2008, Malignant gliomas in adults, N Engl J Med, 59, 492, 10.1056/NEJMra0708126 · DOI · Paper page
- Furnari, 2007, Malignant astrocytic glioma: genetics, biology, and paths to treatment, Genes Dev, 21, 2683, 10.1101/gad.1596707 · DOI · Paper page
- Lefranc, 2005, Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis, J Clin Oncol, 23, 2411, 10.1200/JCO.2005.03.089 · DOI
- Nagai, 2002, Aberrant nuclear factor-kappaB activity and its participation in the growth of human malignant astrocytoma, J Neurosurg, 96, 909, 10.3171/jns.2002.96.5.0909 · DOI
- Naugler, 2008, NF-kappaB and cancer-identifying targets and mechanisms, Curr Opin Genet Dev, 18, 19, 10.1016/j.gde.2008.01.020 · DOI
- Nakada, 2007, Molecular targets of glioma invasion, Cell Mol Life Sci, 64, 458, 10.1007/s00018-007-6342-5 · DOI
- Haupt, 1991, Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice, Cell, 65, 753, 10.1016/0092-8674(91)90383-A · DOI
- van Lohuizen, 1991, Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging, Cell, 65, 737, 10.1016/0092-8674(91)90382-9 · DOI
- Jacobs, 2002, Polycomb repression: from cellular memory to cellular proliferation and cancer, Biochim Biophys Acta, 1602, 151
- Raaphorst, 2005, Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors, Hum Mol Genet, 14 Spec No 1, R93, 10.1093/hmg/ddi111 · DOI
- Molofsky, 2005, Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways, Genes Dev, 19, 1432, 10.1101/gad.1299505 · DOI
- Bruggeman, 2005, Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice, Genes Dev, 19, 1438, 10.1101/gad.1299305 · DOI · Paper page
- Häyry, 2008, Copy number alterations of the polycomb gene BMI-1 in gliomas, Acta Neuropathol, 116, 97, 10.1007/s00401-008-0376-0 · DOI · Paper page
- Valk-Lingbeek, 2004, Stem cells and cancer; the polycomb connection, Cell, 118, 409, 10.1016/j.cell.2004.08.005 · DOI · Paper page
- Jacobs, 1999, Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF, Genes Dev, 13, 2678, 10.1101/gad.13.20.2678 · DOI
- Lee, 2008, Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis, J Invest Dermatol, 128, 9, 10.1038/sj.jid.5700949 · DOI
- Cui, 2007, Bmi-1 is essential for the tumorigenicity of neuroblastoma cells, Am J Pathol, 170, 1370, 10.2353/ajpath.2007.060754 · DOI
- Jarzynka, 2007, ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion, Cancer Res, 67, 7203, 10.1158/0008-5472.CAN-07-0473 · DOI
- Kobori, 2004, Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex, Cell Death Differ, 11, 123, 10.1038/sj.cdd.4401325 · DOI
- Song, 2006, Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells, Cancer Res, 66, 6225, 10.1158/0008-5472.CAN-06-0094 · DOI
- Li, 2008, Astrocyte elevated gene-1 (AEG-1) is a novel prognostic marker for breast cancer progression and overall patient survival, Clin Cancer Res, 14, 3319, 10.1158/1078-0432.CCR-07-4054 · DOI
- Bao, 2004, Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway, Cancer Cell, 5, 329, 10.1016/S1535-6108(04)00081-9 · DOI
- Reed, 2003, Apoptosis-targeted therapies for cancer, Cancer Cell, 3, 17, 10.1016/S1535-6108(02)00241-6 · DOI
- Karin, 2002, NF-kappaB in cancer: from innocent bystander to major culprit, Nat Rev Cancer, 2, 301, 10.1038/nrc780 · DOI
- Godlewski, 2008, Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal, Cancer Res, 68, 9125, 10.1158/0008-5472.CAN-08-2629 · DOI · Paper page
- Datta, 2007, Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways, Cancer Res, 67, 10286, 10.1158/0008-5472.CAN-07-1636 · DOI
- Liu, 2008, Bmi-1 expression predicts prognosis for patients with gastric carcinoma, J Surg Oncol, 97, 267, 10.1002/jso.20934 · DOI
- Hoffmann, 2007, Expression changes in EZH2, but not in BMI-1. SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer, Cancer Biol Ther, 6, 1403, 10.4161/cbt.6.9.4542 · DOI
- Wang, 2008, Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma, J Cancer Res Clin Oncol, 134, 535, 10.1007/s00432-007-0316-8 · DOI
- Bruggeman, 2007, Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma, Cancer Cell, 12, 328, 10.1016/j.ccr.2007.08.032 · DOI
Cited by
Sorted by citations
Mulrooney, T. J., Marsh, J., Urits, I., Seyfried, T. N., & Mukherjee, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018085 · Cited by 75
MiR-128-3p – a gray eminence of the human central nervous system
Kiel, K., Król, S. K., Bronisz, A., & Godlewski, J. (2024) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2024.102141 · Cited by 15
Metadata
- Authors
- Li, J., Gong, L.-Y., Song, L.-B., Jiang, L.-L., Liu, L.-P., Wu, J., Yuan, J., Cai, J.-C., He, M., Wang, L., Zeng, M., Cheng, S.-Y., & Li, M.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 176
- Issue
- 2
- Pages
- 699-709
- ISSN
- 0002-9440
- Cited by
- 84
- References
- 3
- Language
- en
- Licence
- Funders
- National Institutes of Health (CA102011, CA130966)
- Program for New Century Excellent Talents in University
- American Cancer Society (RSG CSM-107111)
- Guangdong Science and Technology Department (07001503, 8251008901000006)
- National Natural Science Foundation of China (30670803, 30770836, 30771110, 30831160517, 30870963, 30872930)
- Ministry of Education of the People's Republic of China (200805580047, PC20071076)
- Ministry of Science and Technology of the People's Republic of China (2005CB724605, 973)
- Natural Science Foundation of Guangdong Province (2006Z3-E4081)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
